Comparative analysis of immune-associated genes in COVID-19, cardiomyopathy and venous thromboembolism
Castaneda, G. E.; Lee, A. C.; Li, W. T.; Chen, C.; Chakladar, J.; Chang, E.; Ongkeko, W.
Show abstract
As of 28 August 2020, there have been 5.88 million Coronavirus Disease 2019 (COVID19) cases and 181,000 COVID-19 related deaths in the United States alone. Given the lack of an effective pharmaceutical treatment for COVID-19, the high contagiousness of the disease and its varied clinical outcomes, identifying patients at risk of progressing to severe disease is crucial for the allocation of valuable healthcare resources during this pandemic. Current research has shown that there is a higher prevalence of cardiovascular comorbidities amongst patients with severe COVID-19 or COVID-19-related deaths, but the link between cardiovascular disease and poorer prognosis is poorly understood. We believe that pre-existing immune dysregulation that accompanies cardiovascular disease predisposes patients to a harmful inflammatory immune response, leading to their higher risk of severe disease. Thus, in this project, we aim to characterize immune dysregulation in patients with cardiomyopathy, venous thromboembolism and COVID-19 patients by looking at immune-associated gene dysregulation, immune infiltration and dysregulated immunological pathways and gene signatures.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Collapsing the list of myocardial infarction-related differential expressed genes into a diagnostic signature 91%
- Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage 91%
- Integration of Machine Learning to Identify Diagnostic Genes in Leukocytes for Acute Myocardial Infarction Patients 90%
Similar papers in this journal
- Expression of ACE2 receptor, soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin (1-7), is modulated in COVID-19 patients 94%
- Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints by peripheral blood immune cells 92%
- Plasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and stratifies outcomes in severe COVID-19 91%
Similar papers in this journal
- Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients 92%
- Novel prognostic determinants of COVID-19-related mortality: a pilot study on severely-ill patients in Russia 92%
- Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients 92%
Similar papers in this journal
- Centhaquine Increases Stroke Volume and Cardiac Output in Patients with Hypovolemic Shock 92%
- Risk Prediction of Coronary Artery Spasm in Patients Without Obstructive Coronary Artery Disease Using a Comprehensive Clinical, Laboratory and Echocardiographic Diagnostic Score 91%
- Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.